LBX Pharmacy Chain JSC
SSE:603883
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
LBX Pharmacy Chain JSC
SSE:603883
|
CN |
|
D
|
D.M. Wenceslao & Associates Inc
XPHS:DMW
|
PH |
Balance Sheet
Balance Sheet Decomposition
LBX Pharmacy Chain JSC
LBX Pharmacy Chain JSC
Balance Sheet
LBX Pharmacy Chain JSC
| Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||
| Cash & Cash Equivalents |
361
|
391
|
467
|
784
|
836
|
1 038
|
756
|
859
|
803
|
680
|
1 396
|
937
|
987
|
|
| Cash |
4
|
7
|
7
|
8
|
10
|
8
|
10
|
8
|
7
|
680
|
1 396
|
937
|
987
|
|
| Cash Equivalents |
357
|
384
|
460
|
776
|
826
|
1 030
|
746
|
851
|
796
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
7
|
13
|
26
|
3
|
3
|
2
|
0
|
|
| Total Receivables |
230
|
282
|
335
|
453
|
669
|
920
|
1 090
|
1 246
|
1 390
|
1 943
|
2 444
|
2 818
|
2 950
|
|
| Accounts Receivables |
211
|
267
|
313
|
420
|
578
|
799
|
940
|
1 073
|
1 150
|
1 376
|
2 078
|
2 224
|
2 340
|
|
| Other Receivables |
19
|
15
|
22
|
33
|
91
|
121
|
150
|
173
|
240
|
567
|
366
|
594
|
610
|
|
| Inventory |
489
|
671
|
739
|
902
|
1 197
|
1 311
|
1 711
|
1 988
|
2 387
|
2 730
|
3 949
|
4 152
|
3 574
|
|
| Other Current Assets |
102
|
146
|
151
|
189
|
241
|
710
|
748
|
970
|
1 030
|
873
|
1 670
|
1 221
|
1 563
|
|
| Total Current Assets |
1 182
|
1 490
|
1 692
|
2 328
|
2 941
|
3 979
|
4 311
|
5 076
|
5 635
|
6 228
|
9 463
|
9 130
|
9 074
|
|
| PP&E Net |
134
|
171
|
197
|
212
|
278
|
448
|
1 216
|
997
|
1 092
|
4 687
|
4 191
|
4 191
|
3 983
|
|
| PP&E Gross |
134
|
171
|
197
|
212
|
278
|
448
|
1 216
|
997
|
1 092
|
4 687
|
4 191
|
4 191
|
3 983
|
|
| Accumulated Depreciation |
78
|
92
|
108
|
132
|
160
|
193
|
240
|
295
|
359
|
2 627
|
3 708
|
4 639
|
5 594
|
|
| Intangible Assets |
42
|
99
|
98
|
120
|
181
|
289
|
341
|
435
|
433
|
466
|
600
|
747
|
842
|
|
| Goodwill |
106
|
318
|
399
|
760
|
1 221
|
1 521
|
1 987
|
2 324
|
2 809
|
3 695
|
5 493
|
5 836
|
5 756
|
|
| Note Receivable |
16
|
21
|
27
|
29
|
37
|
49
|
56
|
64
|
67
|
63
|
75
|
84
|
79
|
|
| Long-Term Investments |
59
|
3
|
0
|
0
|
0
|
0
|
68
|
423
|
565
|
981
|
805
|
436
|
450
|
|
| Other Long-Term Assets |
76
|
78
|
117
|
350
|
250
|
414
|
505
|
605
|
683
|
837
|
770
|
1
|
1
|
|
| Other Assets |
106
|
318
|
399
|
760
|
1 221
|
1 521
|
1 987
|
2 324
|
2 809
|
3 695
|
5 493
|
5 836
|
5 756
|
|
| Total Assets |
1 615
N/A
|
2 180
+35%
|
2 530
+16%
|
3 801
+50%
|
4 910
+29%
|
6 699
+36%
|
8 485
+27%
|
9 924
+17%
|
11 284
+14%
|
16 958
+50%
|
21 397
+26%
|
21 231
-1%
|
21 045
-1%
|
|
| Liabilities | ||||||||||||||
| Accounts Payable |
383
|
503
|
487
|
600
|
830
|
879
|
1 097
|
1 286
|
1 534
|
1 769
|
2 367
|
2 209
|
2 009
|
|
| Accrued Liabilities |
87
|
100
|
111
|
127
|
164
|
215
|
231
|
237
|
289
|
336
|
691
|
596
|
535
|
|
| Short-Term Debt |
325
|
498
|
610
|
447
|
898
|
1 012
|
2 205
|
3 058
|
3 733
|
4 762
|
5 347
|
5 586
|
6 203
|
|
| Current Portion of Long-Term Debt |
0
|
3
|
2
|
0
|
0
|
11
|
807
|
94
|
16
|
904
|
1 290
|
1 484
|
1 204
|
|
| Other Current Liabilities |
86
|
123
|
153
|
319
|
249
|
534
|
606
|
673
|
719
|
841
|
1 151
|
1 280
|
968
|
|
| Total Current Liabilities |
880
|
1 228
|
1 363
|
1 492
|
2 141
|
2 651
|
4 946
|
5 348
|
6 291
|
8 613
|
10 846
|
11 155
|
10 920
|
|
| Long-Term Debt |
0
|
0
|
58
|
0
|
792
|
888
|
84
|
649
|
118
|
3 500
|
3 400
|
2 750
|
2 920
|
|
| Deferred Income Tax |
2
|
16
|
15
|
14
|
24
|
22
|
35
|
33
|
32
|
44
|
34
|
21
|
37
|
|
| Minority Interest |
84
|
107
|
118
|
74
|
95
|
170
|
323
|
388
|
515
|
421
|
568
|
588
|
575
|
|
| Other Liabilities |
0
|
19
|
8
|
2
|
8
|
36
|
51
|
20
|
37
|
22
|
19
|
16
|
13
|
|
| Total Liabilities |
966
N/A
|
1 370
+42%
|
1 562
+14%
|
1 582
+1%
|
3 059
+93%
|
3 768
+23%
|
5 439
+44%
|
6 437
+18%
|
6 994
+9%
|
12 601
+80%
|
14 867
+18%
|
14 530
-2%
|
14 464
0%
|
|
| Equity | ||||||||||||||
| Common Stock |
200
|
200
|
200
|
267
|
267
|
285
|
285
|
287
|
409
|
409
|
585
|
585
|
760
|
|
| Retained Earnings |
295
|
455
|
626
|
866
|
1 022
|
1 313
|
1 463
|
1 825
|
2 324
|
2 739
|
3 314
|
3 970
|
3 852
|
|
| Additional Paid In Capital |
154
|
154
|
142
|
1 085
|
561
|
1 333
|
1 298
|
1 372
|
1 587
|
1 139
|
2 637
|
2 174
|
1 970
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
84
|
37
|
15
|
15
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
53
|
29
|
14
|
43
|
43
|
17
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
57
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
649
N/A
|
810
+25%
|
968
+20%
|
2 218
+129%
|
1 850
-17%
|
2 931
+58%
|
3 046
+4%
|
3 487
+14%
|
4 290
+23%
|
4 358
+2%
|
6 530
+50%
|
6 701
+3%
|
6 581
-2%
|
|
| Total Liabilities & Equity |
1 615
N/A
|
2 180
+35%
|
2 530
+16%
|
3 801
+50%
|
4 910
+29%
|
6 699
+36%
|
8 485
+27%
|
9 924
+17%
|
11 284
+14%
|
16 958
+50%
|
21 397
+26%
|
21 231
-1%
|
21 045
-1%
|
|
| Shares Outstanding | ||||||||||||||
| Common Shares Outstanding |
280
|
280
|
280
|
374
|
374
|
399
|
399
|
401
|
409
|
691
|
757
|
757
|
760
|
|